The National Institutes of Health has launched an effort to find a vaccine that could protect against the influenza pandemic.
The vaccine is expected to be unveiled at the National Academy of Sciences Wednesday.
The goal is to find one that has already shown some success.
“I would expect to see this vaccine being available by the end of the year,” said Dr. Daniel Rabinowitz, chief executive officer of the American Academy of Neurology.
He said the goal is for the vaccine to be ready in time for the 2018 midterm elections, where the U.S. faces a potential election cycle that could see candidates on both sides of the aisle use the flu shot.
“There’s no question that this vaccine is going to be a great candidate for that,” Rabinowitz said.
The effort comes after the vaccine was approved in March by the Food and Drug Administration, which is responsible for approving new vaccines.
The agency’s approval came amid a surge in flu cases in the U, as Americans have begun using their flu shots.
More than 6.6 million people were infected with the H1N1 strain, which was transmitted from people who have not been vaccinated.
It is not clear how many of those infections have been linked to the flu.
In April, the FDA said it would delay the approval of two more influenza vaccines until a vaccine is ready.